These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8523464)

  • 41. Molecular mechanisms regulating the myofilament response to Ca2+: implications of mutations causal for familial hypertrophic cardiomyopathy.
    Palmiter KA; Solaro RJ
    Basic Res Cardiol; 1997; 92 Suppl 1():63-74. PubMed ID: 9202846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene.
    Sipola P; Lauerma K; Husso-Saastamoinen M; Kuikka JT; Vanninen E; Laitinen T; Manninen H; Niemi P; Peuhkurinen K; Jääskeläinen P; Laakso M; Kuusisto J; Aronen HJ
    Radiology; 2003 Jan; 226(1):129-37. PubMed ID: 12511681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy.
    Daehmlow S; Erdmann J; Knueppel T; Gille C; Froemmel C; Hummel M; Hetzer R; Regitz-Zagrosek V
    Biochem Biophys Res Commun; 2002 Oct; 298(1):116-20. PubMed ID: 12379228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Hämäläinen L; Melin J; Kärkkäinen S; Peuhkurinen K; Nieminen MS; Laakso M; ; Kuusisto J
    Ann Med; 2014 Sep; 46(6):424-9. PubMed ID: 24888384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A mouse model of familial hypertrophic cardiomyopathy caused by a alpha-tropomyosin mutation.
    Prabhakar R; Petrashevskaya N; Schwartz A; Aronow B; Boivin GP; Molkentin JD; Wieczorek DF
    Mol Cell Biochem; 2003 Sep; 251(1-2):33-42. PubMed ID: 14575301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A novel missense mutation, K124N, in the troponin T gene of Chinese populations with hypertrophic cardiomyopathy].
    An FS; Zhang Y; Li DQ; Yang XS; Li L; Zhang C; Yan ML; Wang Y; An GP
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1340-3. PubMed ID: 15387941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
    Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
    DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant alpha-tropomyosins in adult cardiac myocytes.
    Michele DE; Albayya FP; Metzger JM
    Nat Med; 1999 Dec; 5(12):1413-7. PubMed ID: 10581085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel mutation in the alpha-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy.
    Regitz-Zagrosek V; Erdmann J; Wellnhofer E; Raible J; Fleck E
    Circulation; 2000 Oct; 102(17):E112-6. PubMed ID: 11044437
    [No Abstract]   [Full Text] [Related]  

  • 50. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood.
    Van Driest SL; Will ML; Atkins DL; Ackerman MJ
    Am J Cardiol; 2002 Nov; 90(10):1123-7. PubMed ID: 12423715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
    Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
    Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure.
    Arbustini E; Fasani R; Morbini P; Diegoli M; Grasso M; Dal Bello B; Marangoni E; Banfi P; Banchieri N; Bellini O; Comi G; Narula J; Campana C; Gavazzi A; Danesino C; Viganò M
    Heart; 1998 Dec; 80(6):548-58. PubMed ID: 10065021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction.
    Muthuchamy M; Pieples K; Rethinasamy P; Hoit B; Grupp IL; Boivin GP; Wolska B; Evans C; Solaro RJ; Wieczorek DF
    Circ Res; 1999 Jul; 85(1):47-56. PubMed ID: 10400910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients.
    Konno T; Shimizu M; Ino H; Matsuyama T; Yamaguchi M; Terai H; Hayashi K; Mabuchi T; Kiyama M; Sakata K; Hayashi T; Inoue M; Kaneda T; Mabuchi H
    J Am Coll Cardiol; 2003 Mar; 41(5):781-6. PubMed ID: 12628722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural destabilization of tropomyosin induced by the cardiomyopathy-linked mutation R21H.
    Ly T; Krieger I; Tolkatchev D; Krone C; Moural T; Samatey FA; Kang C; Kostyukova AS
    Protein Sci; 2018 Feb; 27(2):498-508. PubMed ID: 29105867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding.
    van de Meerakker JB; Christiaans I; Barnett P; Lekanne Deprez RH; Ilgun A; Mook OR; Mannens MM; Lam J; Wilde AA; Moorman AF; Postma AV
    Biochim Biophys Acta; 2013 Apr; 1833(4):833-9. PubMed ID: 23147248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
    Doolan A; Tebo M; Ingles J; Nguyen L; Tsoutsman T; Lam L; Chiu C; Chung J; Weintraub RG; Semsarian C
    J Mol Cell Cardiol; 2005 Feb; 38(2):387-93. PubMed ID: 15698845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single-strand conformation polymorphism analysis on the delta-sarcoglycan gene in Japanese patients with hypertrophic cardiomyopathy.
    Date M; Otsu K; Nishida K; Toyofuku T; Matsumura Y; Morita T; Hirotani S; Okazaki Y; Hayashizaki Y; Nigro V; Kuzuya T; Tada M; Hori M
    Am J Cardiol; 2000 Jun; 85(11):1315-8. PubMed ID: 10831946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.